(Total Views: 364)
Posted On: 03/19/2020 9:57:20 PM
Post# of 36566
I decided to start emailing/tweeting as many people I can to help spread the word. Here is an email that I plan to send to a reporter. Please feel free to copy and paste the text and attach today's PR and forward to as many people as you can think of. Time is of the essence! Thank you very much!
___________________
Subject - Small U.S. Biotech Company can initiate human clinical trials in 3 to 5 months!
Dear XXX,
I read your article on Coronavirus which was published on March 1, 2020. I’d like to forward you information on Generex Biotechnology. Generex has developed a proprietary, patented Ii-Key immune system activation technology that holds promise for stopping pandemic viral outbreaks like the current coronavirus pandemic. Generex has a signed contract for the clinical & commercial development of vaccines with partners in China. Generex is seeking government and private partners to develop and distribute the eventual Ii-Key-SARS-COV-2 peptide vaccine on a global basis. Since time is of essence, it is hard for a small biotech company to do this alone. Please spread the word and help Generex stop the pandemic outbreak sooner than later.
Attached is a copy of Generex’s press release today, and here is the link that has the link to Generex’s Covid-19 vaccine project https://www.generex.com/covid-19.
The timeline for commercial manufacturing & distribution for the vaccine is between 5 to 9 months!!
Please email covid-19@nugenerexio.com if you are interested in doing an interview or have any questions.
___________________
Subject - Small U.S. Biotech Company can initiate human clinical trials in 3 to 5 months!
Dear XXX,
I read your article on Coronavirus which was published on March 1, 2020. I’d like to forward you information on Generex Biotechnology. Generex has developed a proprietary, patented Ii-Key immune system activation technology that holds promise for stopping pandemic viral outbreaks like the current coronavirus pandemic. Generex has a signed contract for the clinical & commercial development of vaccines with partners in China. Generex is seeking government and private partners to develop and distribute the eventual Ii-Key-SARS-COV-2 peptide vaccine on a global basis. Since time is of essence, it is hard for a small biotech company to do this alone. Please spread the word and help Generex stop the pandemic outbreak sooner than later.
Attached is a copy of Generex’s press release today, and here is the link that has the link to Generex’s Covid-19 vaccine project https://www.generex.com/covid-19.
The timeline for commercial manufacturing & distribution for the vaccine is between 5 to 9 months!!
Please email covid-19@nugenerexio.com if you are interested in doing an interview or have any questions.
(7)
(0)
